Enantioselective synthesis of (R)-(+)- and (S)-(−)-higenamine and their analogues with effects on platelet aggregation and experimental animal model of disseminated intravascular coagulationMi Kyung Pyo, Hye Sook Yun‐Choi, Ki Churl Chang et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 56
Effects of higenamine and its 1-naphthyl analogs, YS-49 and YS-51, on platelet TXA2 synthesis and aggregationMi Kyung Pyo, Hye Sook Yun‐Choi, Jeong Mi Kim et al.|Thrombosis Research|2006Cited by 32
The Effects of Higenamine on LPS-Induced Experimental Disseminated Intravascular Coagulation (DIC) in RatsHye Sook Yun‐Choi, Duck‐Hyung Lee, Mi Kyung Pyo et al.|Planta Medica|2002Cited by 24
(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulationEun Jung Park, Ki Churl Chang, Young‐Min Kim et al.|European Journal of Pharmacology|2016Cited by 22
A limited series of synthetic tetrahydroisoquinoline alkaloids reduce inflammatory gene iNOS via inhibition of p-STAT-1 and suppress HMGB1 secretion in LPS-treated mice lung tissueGyung Hyuck Ko, Ki Churl Chang, Eun‐Jung Park et al.|International Immunopharmacology|2017Cited by 10